Serina Therapeutics Stock Quote SER - Stock Price, News, Charts, Message Board, Trades

Unlock more advanced trading tools

Join ADVFN today

Current Price

8.46

Bid

Ask

Volume

1,145

8.20 Day's Range 8.46

8.01 52 Week Range 19.93

Market Cap

321.065M

Previous Close

8.30

Open

8.20

Last Trade

100

8.46

Last Trade Time

Financial Volume

$ 9,510

VWAP

8.3057

Average Volume (3m)

4,590

Shares Outstanding

37,951,000

Dividend Yield

PE Ratio

-21.69

Earnings Per Share (EPS)

-0.39

Revenue

142k

Net Profit

-14.8M

AgeX Therapeutics Inc is a biotechnology company engaged in the development and commercialization of novel therapeutics targeting human aging. The firm through its PureStem and induced Tissue Regeneration (iTR) technologies develop medicines designed to address some of the unsolved problems in aging... AgeX Therapeutics Inc is a biotechnology company engaged in the development and commercialization of novel therapeutics targeting human aging. The firm through its PureStem and induced Tissue Regeneration (iTR) technologies develop medicines designed to address some of the unsolved problems in aging. Its PureStem derived cell-based therapeutic candidates in development are AGEX-VASC1, AGEX-BAT1 and AGEX-iTR1547. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

serinatherapeutics.com

Headquarters

Dover, Delaware, USA

Founded

1970

Serina Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the American Stock Exchange with ticker SER. The last closing price for Serina Therapeutics was $8.30. Over the last year, Serina Therapeutics shares have traded in a share price range of $ 8.01 to $ 19.93.

Serina Therapeutics currently has 37,951,000 shares outstanding. The market capitalization of Serina Therapeutics is $321.07 million. Serina Therapeutics has a price to earnings ratio (PE ratio) of -21.69.

Serina Therapeutics Appoints Dr. Simba Gill as Executive Chairman

- Dr. Gill brings extensive leadership experience in transformative biotechnology platforms and drug development - HUNTSVILLE, AL, April 17, 2024 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc...

Serina Therapeutics Announces Completion of Merger with AgeX Therapeutics

Shares of Serina to commence trading on NYSE American under the ticker symbol “SER” on March 27, 2024Lead candidate SER-252, POZ-apomorphine preclinical studies anticipated to be completed in the...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.09	-1.05263157895	8.55	9.34	8.1	927	8.60674498	CS
4	-3.04	-26.4347826087	11.5	12.815	8.01	1640	10.58001903	CS
12	-3.22	-27.5684931507	11.68	19.93	8.01	4590	12.9259272	CS
26	-3.22	-27.5684931507	11.68	19.93	8.01	4590	12.9259272	CS
52	-3.22	-27.5684931507	11.68	19.93	8.01	4590	12.9259272	CS
156	-3.22	-27.5684931507	11.68	19.93	8.01	4590	12.9259272	CS
260	-3.22	-27.5684931507	11.68	19.93	8.01	4590	12.9259272	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
NUVOHoldco Nuvo Group DG Ltd	$ 5.2108 (155.43%)	43.44M
XBPXBP Europe Holdings Inc	$ 3.4999 (65.09%)	55.73M
PLTNPlutoniam Acquisition Corporation	$ 9.40 (56.41%)	1.43M
PRFTPerficient Inc	$ 73.27 (52.30%)	11.68M
NRXPNRX Pharmaceuticals Inc	$ 3.05 (45.24%)	9.31M
LYRALyra Therapeutics Inc	$ 0.519 (-87.12%)	108.65M
GLYCGlycoMimetics Inc	$ 0.3165 (-82.70%)	41M
EYPTEyePoint Pharmaceuticals Inc	$ 11.15 (-43.52%)	9.65M
LGHLWLion Group Holding Ltd	$ 0.0047 (-32.86%)	100.74k
MMATMeta Materials Inc	$ 2.44 (-27.16%)	580.58k
LYRALyra Therapeutics Inc	$ 0.519 (-87.12%)	108.65M
SQQQProShares UltraPro Short QQQ	$ 10.70 (-3.43%)	94.71M
NKLANikola Corporation	$ 0.6497 (-1.19%)	89.11M
MARAMarathon Digital Holdings Inc	$ 20.695 (18.12%)	87.05M
TSLATesla Inc	$ 184.76 (1.97%)	84.41M